Meta-analysis of ifosfamide-based combination chemotherapy in advanced soft tissue sarcoma.
about
Species differences in tumour responses to cancer chemotherapyLeiomyosarcoma of the sigmoid colon with multiple liver metastases and gastric cancer: a case report.Combining targeted agents with modern radiotherapy in soft tissue sarcomas.Advanced well-differentiated/dedifferentiated liposarcomas: role of chemotherapy and survival.Epidemiology and therapies for metastatic sarcomaSuccessful treatment of advanced malignant fibrous histiocytoma of the right forearm with apatinib: a case reportMolecular targeted therapies in non-GIST soft tissue sarcomas: what the radiologist needs to knowPhase II study of sunitinib malate, a multitargeted tyrosine kinase inhibitor in patients with relapsed or refractory soft tissue sarcomas. Focus on three prevalent histologies: leiomyosarcoma, liposarcoma and malignant fibrous histiocytoma.High-dose chemotherapy consolidation for chemosensitive advanced soft tissue sarcoma patients: an open-label, randomized controlled trial.Current diagnosis and management of retroperitoneal sarcoma.Metastatic soft tissue sarcoma chemotherapy: an opportunity for personalized medicine.Extraskeletal myxoid chondrosarcoma: a case report of complete remission by chemotherapy and review of the literatureSystemic therapy in soft tissue sarcomas: past, present and future.Anti-cancer palladium complexes: a focus on PdX2L2, palladacycles and related complexes.The safety and efficacy of trabectedin for the treatment of liposarcoma or leiomyosarcoma.Pharmacological therapies for Liposarcoma.Clinical benefit of second-line palliative chemotherapy in advanced soft-tissue sarcoma.Consolidation with high-dose chemotherapy and stem cell support for responding patients with metastatic soft tissue sarcomas: prospective, single-institutional phase II study.The Danish experience with trabectedin treatment for metastatic sarcoma: Importance of hyponatremia.Targeted therapy in sarcomas: mammalian target of rapamycin inhibitors from bench to bedside.Spotlight on olaratumab in the treatment of soft-tissue sarcoma: design, development, and place in therapy.Myxofibrosarcoma primary cultures: molecular and pharmacological profile.Primary Peritoneal Angiosarcoma Metastatic to Liver and Bone without History of Radiation Therapy.Aldoxorubicin: a tumor-targeted doxorubicin conjugate for relapsed or refractory soft tissue sarcomas.Transmembrane TNF-alpha promotes chemoresistance in breast cancer cells.
P2860
Q28080727-D0A763E1-87E3-4DB5-AC3C-6DF21784A5C5Q34360332-4DA784E9-7F26-43AA-B2AC-50251E46FEBAQ34396047-7296FA9E-A79E-484F-8257-EB7F2552FF76Q34633368-DE559CC7-6B9A-48E9-9B87-3861B7995989Q34652142-0525B35A-E709-4F76-AEC4-866AE3141839Q34675903-1B076509-CAE1-4FEA-8162-E0A92E3D7B8EQ36819466-08209A22-F1D3-4380-9304-0FE0D0CD03B0Q37181235-EFD0931A-14C5-484D-8C70-BECC2337723DQ37886394-64FD7613-CE89-474D-A87A-19187DCD75DAQ37888460-97CA3C0F-FB6E-4CD9-BD4C-AEB3D8E38D04Q37888461-6B2816FA-A753-4C43-B029-C2817372C71CQ37982373-21936E69-F93F-4492-A047-F90E335595D4Q38064436-7ECB8D09-57CC-4193-8F40-4C7B3ECB4212Q38203819-E569D35C-4CB5-4401-B863-B16E9D9B0F97Q38797843-9DE4060D-7327-4E85-B5B7-CC16BAD246DDQ38991731-6C680504-789D-4734-B59B-CD1C48DC2944Q40700785-6B66A6AC-1033-4680-B64D-850E2B53F170Q43236387-2621BF89-0A83-4B1D-9185-777E529A3AA2Q44301485-49AAEF40-CF0F-424F-BAC5-F619BECC966DQ45743838-0B5548D7-87B9-4BC2-A596-143CE6C27B2BQ47109507-83715084-68DA-40DF-A005-8AB84A2E19A4Q49956275-701E65D6-B9BE-4DA7-9F7C-C8D2D5546ADDQ55082653-68FAE221-8E9F-4E8E-9FB3-A88F69B85D84Q55092685-35767085-9610-4CAD-AC11-CF24A5006256Q55274989-54CC5AAD-D50B-4D1B-86F4-BB3CAE0FFFB7
P2860
Meta-analysis of ifosfamide-based combination chemotherapy in advanced soft tissue sarcoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Meta-analysis of ifosfamide-ba ...... advanced soft tissue sarcoma.
@en
Meta-analysis of ifosfamide-ba ...... advanced soft tissue sarcoma.
@nl
type
label
Meta-analysis of ifosfamide-ba ...... advanced soft tissue sarcoma.
@en
Meta-analysis of ifosfamide-ba ...... advanced soft tissue sarcoma.
@nl
prefLabel
Meta-analysis of ifosfamide-ba ...... advanced soft tissue sarcoma.
@en
Meta-analysis of ifosfamide-ba ...... advanced soft tissue sarcoma.
@nl
P2093
P1476
Meta-analysis of ifosfamide-ba ...... advanced soft tissue sarcoma.
@en
P2093
Adam E Haynes
Denise Stys-Norman
Jawaid Younus
Martin Blackstein
Members of the Sarcoma Disease ...... Program in Evidence-Based Care
Shailendra Verma
P304
P356
10.1016/J.CTRV.2008.01.005
P577
2008-03-03T00:00:00Z